EARNINGS2020 Earnings Calendar: When Do Top Companies Report This Quarter?By Steve FiorilloJan 22, 2020 8:49 AM EST
PRESS RELEASESNew Head-to-Head Phase 3 Data Show SKYRIZI™ (risankizumab) Superior To Cosentyx® (secukinumab) Across Primary And All Ranked Secondary Endpoints In Adults With Moderate To Severe Plaque Psoriasis At 52 WeeksBy PR NewswireJan 14, 2020 8:45 AM EST
PRESS RELEASESAbbVie To Host Fourth-Quarter And Full-Year 2019 Earnings Conference CallBy PR NewswireJan 13, 2020 8:00 AM EST
PRESS RELEASESAbbVie Announces Leadership Team And Creation Of New Business, Allergan Aesthetics, Upon Completion Of AcquisitionBy PR NewswireJan 8, 2020 3:00 AM EST
PRESS RELEASESAbbVie To Present At The 38th Annual J.P. Morgan Healthcare ConferenceBy PR NewswireJan 3, 2020 8:00 AM EST
JIM CRAMERGreat Investors Need Good Judgment: Cramer's 'Mad Money' Recap (Friday 12/27/19)By Scott RuttDec 27, 2019 7:01 PM EST
JIM CRAMERSpotting the Winners: Cramer's 'Mad Money' Recap (Thursday 12/19/19)By Scott RuttDec 19, 2019 9:25 PM EST
INVESTINGBeiGene Shares Tumble After Cancer Drug Challenge to Johnson & Johnson Misses Late-Stage GoalsBy Martin BaccardaxDec 16, 2019 9:37 AM EST
STOCKSAbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis DrugBy Tony OwusuDec 3, 2019 10:06 AM EST
JIM CRAMERAbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning RoundBy Scott RuttNov 21, 2019 8:39 PM EST
CORPORATE GOVERNANCEAbbott Labs Taps Operating Chief Robert Ford as CEO, Succeeding Miles WhiteBy Rob DanielNov 13, 2019 10:54 AM EST
INVESTINGAbbVie Selling Up to $28 Billion in Bonds to Acquire Allergan: ReportBy Scott Van VoorhisNov 12, 2019 10:00 AM EST
EARNINGSAllergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie TakeoverBy Martin BaccardaxNov 5, 2019 9:40 AM EST
INVESTINGAbbVie Posts Stronger-Than-Expected Earnings, Lifts ForecastBy M. Corey GoldmanNov 1, 2019 9:35 AM EDT
MARKETSJobs Report, Exxon, Pinterest, Amgen, U.S. Steel - 5 Things You Must Know FridayBy Joseph WoelfelNov 1, 2019 7:01 AM EDT
JIM CRAMERGreat Investors Need Good Judgment: Cramer's 'Mad Money' RecapBy Scott RuttOct 15, 2019 6:59 PM EDT
PERSONAL FINANCEDividend Investing: What Is It and How Does It Work?By Roger WohlnerSep 23, 2019 12:36 PM EDT
